ERCC1 and ovarian cancer: For example, ERCC1 expression levels have an inverse correlation with either response to platinum-based adjuvant chemotherapy or survival in patients with ovarian cancer, colorectal cancer, and non-small cell lung cancer (NSCLC) [38–40].